CG
AERI

Colony Group’s Aerie Pharmaceuticals AERI Stock Holding History

Colony Group’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,370
Closed -$261K – 498
2017
Q3 		$261K Hold
5,370
– – 0.02% 381
2017
Q2 		$282K Hold
5,370
– – 0.02% 356
2017
Q1 		$244K Sell
5,370
-3,500
-39% -$156K 0.02% 250
2016
Q4 		$336K Sell
8,870
-3,000
-25% -$113K 0.04% 225
2016
Q3 		$448K Hold
11,870
– – 0.05% 190
2016
Q2 		$209K Sell
11,870
-1,000
-8% -$16.2K 0.02% 232
2016
Q1 		$157K Hold
12,870
– – 0.02% 237
2015
Q4 		$313K Hold
12,870
– – 0.03% 312
2015
Q3 		$228K Buy
+12,870
New +$233K 0.03% 316

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Colony Group's AERI Position: Q4 2017 in Review

Colony Group sold out of Aerie Pharmaceuticals (AERI) in Q4 2017, closing a stake of 5,370 shares — an estimated $261K sold.

Colony Group first reported a position in AERI in Q3 2015 and held it in 9 quarters. The position peaked at $448K in Q3 2016. 179 funds tracked by Wall St. Rank hold AERI as of Q4 2017.

  • Colony Group reported no remaining Aerie Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Colony Group sold 5,370 Aerie Pharmaceuticals shares in Q4 2017, an estimated $261K.
  • Colony Group first reported a position in Aerie Pharmaceuticals in Q3 2015 and held it in 9 quarters.
  • Colony Group's Aerie Pharmaceuticals position peaked at $448K in Q3 2016.
  • 179 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2017.

Based on Colony Group's 13F filing for Q4 2017, filed 14 Feb 2018.